Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 2, 2026.

WAO Guideline for the Management of Hereditary Angioedema

Timothy Craig, Emel Aygören Pürsün, Konrad Bork and 15 more

World Allergy Organization Journal · 2012 · CC BY-NC-ND

doi:10.1097/wox.0b013e318279affa

Abstract

: Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians and other health care providers. For this reason we convened a group of specialists that focus upon HAE from around the world to develop not only a consensus on diagnosis and management of HAE, but to also provide evidence based grades, strength of evidence and classification for the consensus. Since both consensus and evidence grading were adhered to the document meets criteria as a guideline. The outcome of the guideline is to improve diagnosis and management of patients with HAE throughout the world and to help initiate uniform care and availability of therapies to all with the diagnosis no matter where the residence of the individual with HAE exists.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 141

  1. 1.

    Brozek JL Akl EA Alonso-Coello P Lang D Jaeschke R Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventionsAllergy2009 5669677

    Not in our library10.1111/j.1398-9995.2009.01973.x

  2. 2.

    Cicardi M Bork K Caballero T Craig T Li HH Longhurst H Reshef A Zuraw B Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working GroupAllergy2012 5147157

    Not in our library10.1111/j.1398-9995.2011.02751.x

  3. 3.

    Munch EP Weeke B Non-hereditary angioedema treated with tranexamic acid. A 6-month placebo controlled trial with follow-up 4 years laterAllergy1985 59297

    Not in our library10.1111/j.1398-9995.1985.tb02666.x

  4. 4.

    Lewis JH Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disordersAliment Pharmacol Ther1991 5suppl 11524

    Not in our library10.1111/j.1365-2036.1991.tb00745.x

  5. 5.

    Gluszko P Undas A Amenta S Szczeklik A Schmaier AH Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitorJ Lab Clin Med1994 5232240

    Not in our library

  6. 6.

    Cicardi M Mannucci PM Castelli R Rumi MG Agostoni A Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrateTransfusion1995 5209212

    Not in our library10.1046/j.1537-2995.1995.35395184276.x

  7. 7.

    Waytes AT Rosen FS Frank MM Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrateN Engl J Med1996 516301634

    Not in our library10.1056/nejm199606203342503

  8. 8.

    Cicardi M Castelli R Zingale LC Agostoni A Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patientsJ Allergy Clin Immunol1997 5194196

    Not in our library10.1016/s0091-6749(97)70095-2

  9. 9.

    Goring HD Bork K Späth PJ Bauer R Ziemer A Hintner H Wüthrich B Hereditary angioedema in the German-speaking region [in German]Hautarzt1998 5114122

    Not in our library10.1007/s001050050710

  10. 10.

    Kunschak M Engl W Maritsch F Rosen FS Eder G Zerlauth G Schwarz HP A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedemaTransfusion1998 5540549

    Not in our library10.1046/j.1537-2995.1998.38698326333.x

  11. 11.

    Farkas H Gyeney L Gidófalvy E Füst G Varga L The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental proceduresJ Oral Maxillofac Surg1999 5404408

    Not in our library10.1016/s0278-2391(99)90280-x

  12. 12.

    Bork K Barnstedt SE Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedemaArch Intern Med2001 5714718

    Not in our library10.1001/archinte.161.5.714

  13. 13.

    Gompels MM Lock RJ Gidófalvy E Füst G Varga L A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiencyJ Clin Pathol2002 5145147

    Not in our library10.1136/jcp.55.2.145

  14. 14.

    Weiler JM Quinn SA Woodworth GG Brown DD Layton TA Maves KK Does heparin prophylaxis prevent exacerbations of hereditary angioedema?J Allergy Clin Immunol2002 59951000

    Not in our library10.1067/mai.2002.124892

  15. 15.

    Szeplaki G Varga L Valentin S Kleiber M Karádi I Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedemaJ Allergy Clin Immunol2005 5864869

    Not in our library10.1016/j.jaci.2004.12.1130

  16. 16.

    van Doorn MB Burggraaf J van Dam T Eerenberg A Levi M A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedemaJ Allergy Clin Immunol2005 5876883

    Not in our library10.1016/j.jaci.2005.05.019

  17. 17.

    Bas M Bier H Greve J Kojda G Hoffmann TK Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibantAllergy2006 514901492

    Not in our library10.1111/j.1398-9995.2006.01197.x

  18. 18.

    Bork K Frank J Grundt B Schlattmann P Nussberger J Kreuz W Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)J Allergy Clin Immunol2007 514971503

    Not in our library10.1016/j.jaci.2007.02.012

  19. 19.

    Ott HW Mattle V Hadziomerovic D Licht P Döinghaus K Treatment of hereditary angioneurotic oedema (HANE) with tiboloneClin Endocrinol (Oxf)2007 5180184

    Not in our library10.1111/j.1365-2265.2006.02704.x

  20. 20.

    Schneider L Lumry W Vegh A Williams AH Schmalbach T Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitorJ Allergy Clin Immunol2007 5416422

    Not in our library10.1016/j.jaci.2007.04.028

  21. 21.

    Varga L Biro A Széplaki G Tóth L Horváth A Füst G Farkas H Anti-cholesterol antibody levels in hereditary angioedemaJ Cell Mol Med2007 513771383

    Not in our library10.1111/j.1582-4934.2007.00124.x

  22. 22.

    Visy B Fust G Bygum A Bork K Longhurst H Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedemaHelicobacter2007 5251257

    Not in our library10.1111/j.1523-5378.2007.00501.x

  23. 23.

    Birjmohun RS Kees Hovingh G Stroes ES Hofstra JJ Dallinga-Thie GM Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedemaClin Ther2008 523142323

    Not in our library10.1016/j.clinthera.2008.12.021

  24. 24.

    Cedzynski M Madalinski K Gregorek H Swierzko AS Nowicka E Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adultsArch Immunol Ther Exp (Warsz)2008 56975

    Not in our library10.1007/s00005-008-0004-7

  25. 25.

    Szegedi R Szeplaki G Varga L Prohászka Z Széplaki Z Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patientsAtherosclerosis2008 5184191

    Not in our library10.1016/j.atherosclerosis.2007.09.025

  26. 26.

    Craig TJ Levy RJ Wasserman RL Bewtra AK Hurewitz D Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksJ Allergy Clin Immunol2009 5801808

    Not in our library10.1016/j.jaci.2009.07.017

  27. 27.

    Kreuz W Martinez-Saguer I Aygören-Pürsün E Rusicke E Heller C Klingebiel T C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxisTransfusion2009 519871995

    Not in our library10.1111/j.1537-2995.2009.02230.x

  28. 28.

    Bas M Greve J Stelter K Bier H Stark T Hoffmann TK Kojda G Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case seriesAnn Emerg Med2010 5278282

    Not in our library10.1016/j.annemergmed.2010.03.032

  29. 29.

    Bernstein JA Ritchie B Levy RJ Wasserman RL Bewtra AK Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacksAnn Allergy Asthma Immunol2010 5149154

    Not in our library10.1016/j.anai.2010.06.005

  30. 30.

    Cicardi M Banerji A Bracho F Malbrán A Rosenkranz B Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedemaN Engl J Med2010 5532541

    Not in our library10.1056/nejmoa0906393

  31. 31.

    Cicardi M Levy RJ McNeil DL Li HH Sheffer AL Ecallantide for the treatment of acute attacks in hereditary angioedemaN Engl J Med2010 5523531

    Not in our library10.1056/nejmoa0905079

  32. 32.

    Craig TJ Wasserman RL Levy RJ Bewtra AK Schneider L Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedemaJ Clin Immunol2010 5823829

    Not in our library10.1007/s10875-010-9442-1

  33. 33.

    Levy RJ Lumry WR McNeil DL Li HH Campion M Horn PT Pullman WE EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedemaAnn Allergy Asthma Immunol2010 5523529

    Not in our library10.1016/j.anai.2010.04.012

  34. 34.

    Zuraw B Cicardi M Levy RJ Nuijens JH Relan A Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedemaJ Allergy Clin Immunol2010 5821827.e814

    Not in our library10.1016/j.jaci.2010.07.021

  35. 35.

    Zuraw BL Busse PJ White M Jacobs J Lumry W Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedemaN Engl J Med2010 5513522

    Not in our library10.1056/nejmoa0805538

  36. 36.

    Bissler JJ Donaldson VH Davis AE Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edemaHum Genet1994 5265269

    Not in our library10.1007/bf00212020

  37. 37.

    Zhang Y Dipple KM Vilain E Huang BL Finlayson G AluY insertion (IVS4-52ins316alu) in the glycerol kinase gene from an individual with benign glycerol kinase deficiencyHum Mutat2000 5316323

    Not in our library10.1002/(sici)1098-1004(200004)15:4<316::aid-humu3>3.0.co;2-9

  38. 38.

    Bowen T Hebert J Ritchie B Burnham J MacSween M Management of hereditary angioedema: a Canadian approachTransfus Apher Sci2003 5205214

    Not in our library10.1016/j.transci.2003.08.009

  39. 39.

    Bowen T Cicardi M Farkas H Bork K Kreuz W Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary AngioedemaJ Allergy Clin Immunol2004 5629637

    Not in our library10.1016/j.jaci.2004.06.043

  40. 40.

    Bracho FA Hereditary angioedemaCurr Opin Hematol2005 5493498

    Not in our library10.1097/01.moo.0000179805.57486.4e

  41. 41.

    Chinen J Shearer WT Basic and clinical immunologyJ Allergy Clin Immunol2005 5411418

    Not in our library10.1016/j.jaci.2005.05.010

  42. 42.

    Gompels MM Lock RJ Abinun M Bethune CA Davies G C1 inhibitor deficiency: consensus documentClin Exp Immunol2005 5379394

    Not in our library10.1111/j.1365-2249.2005.02726.x

  43. 43.

    Bowen T Cicardi M Bork K Zuraw B Frank M Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary AngioedemaAnn Allergy Asthma Immunol2008 5suppl 2S30S40

    Not in our library10.1016/s1081-1206(10)60584-4

  44. 44.

    Bowen T Hereditary angioedema consensus 2010Allergy Asthma Clin Immunol2010 513

    Not in our library10.1186/1710-1492-6-13

  45. 45.
  46. 46.
  47. 47.
  48. 48.

    Dinkelacker E Ueber acutes Oedem [dissertation]1882 Kiel, Germany: Unversity of Kiel

    Not in our library

  49. 49.

    Rosen FS Austen KF The "neurotic edema" (hereditary angioedema)N Engl J Med1969 513561357

    Not in our library10.1056/nejm196906122802414

  50. 50.

    Cicardi M Bergamaschini L Marasini B Boccassini G Tucci A Agostoni A Hereditary angioedema: an appraisal of 104 casesAm J Med Sci1982 529

    Not in our library10.1097/00000441-198207000-00001

  51. 51.

    Bork K Meng G Staubach P Hardt J Hereditary angioedema: new findings concerning symptoms, affected organs, and courseAm J Med2006 5267274

    Not in our library10.1016/j.amjmed.2005.09.064

  52. 52.

    Longhurst HJ Bork K Hereditary angioedema: causes, manifestations and treatmentBr J Hosp Med (Lond)2006 5654657

    Not in our library10.12968/hmed.2006.67.12.22439

  53. 53.

    Kaplan AP Greaves MW AngioedemaJ Am Acad Dermatol2005 5373388quiz 389-392

    Not in our library10.1016/j.jaad.2004.09.032

  54. 54.

    Seidman MD Lewandowski CA Sarpa JR Potesta E Schweitzer VG Angioedema related to angiotensin-converting enzyme inhibitorsOtolaryngol Head Neck Surg1990 5727731

    Not in our library10.1177/019459989010200617

  55. 55.

    Nussberger J Cugno M Amstutz C Cicardi M Pellacani A Agostoni A Plasma bradykinin in angio-oedemaLancet1998 516931697

    Not in our library10.1016/s0140-6736(97)09137-x

  56. 56.

    Agostoni A Cicardi M Cugno M Zingale LC Gioffré D Nussberger J Angioedema due to angiotensin-converting enzyme inhibitorsImmunopharmacology1999 52125

    Not in our library10.1016/s0162-3109(99)00107-1

  57. 57.

    Rosen FS Pensky J Donaldson V Charache P Hereditary angioneurotic edema: two genetic variantsScience1965 5957958

    Not in our library10.1126/science.148.3672.957

  58. 58.

    Roche O Blanch A Caballero T Sastre N Callejo D López-Trascasa M Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in SpainAnn Allergy Asthma Immunol2005 5498503

    Not in our library10.1016/s1081-1206(10)61121-0

  59. 59.

    Bygum A Hereditary angio-oedema in Denmark: a nationwide surveyBr J Dermatol2009 511531158

    Not in our library10.1111/j.1365-2133.2009.09366.x

  60. 60.

    Donaldson VH Rosen FS Action of complement in hereditary angioneurotic edema: the role of C'1-esteraseJ Clin Invest1964 522042213

    Not in our library10.1172/jci105094

  61. 61.

    Donaldson VH Rosen FS Bing DH Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasmaAdv Exp Med Biol1983 5183191

    Not in our library

  62. 62.

    Kaplan AP Joseph K Silverberg M Pathways for bradykinin formation and inflammatory diseaseJ Allergy Clin Immunol2002 5195209

    Not in our library10.1067/mai.2002.121316

  63. 63.

    Donaldson VH Kinin formation in hereditary angioneurotic edema (HANE) plasmaInt Arch Allergy Appl Immunol1973 5206209

    Not in our library10.1159/000231029

  64. 64.

    Fields T Ghebrehiwet B Kaplan AP Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykininJ Allergy Clin Immunol1983 55460

    Not in our library10.1016/0091-6749(83)90052-0

  65. 65.

    Maurer M Bader M Bas M Bossi F Cicardi M New topics in bradykinin researchAllergy2011 513971406

    Not in our library10.1111/j.1398-9995.2011.02686.x

  66. 66.

    Binkley KE Davis A III Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedemaJ Allergy Clin Immunol2000 5546550

    Not in our library10.1067/mai.2000.108106

  67. 67.

    Bork K Barnstedt SE Koch P Traupe H Hereditary angioedema with normal C1-inhibitor activity in womenLancet2000 5213217

    Not in our library10.1016/s0140-6736(00)02483-1

  68. 68.

    Bork K Gul D Dewald G Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and menBr J Dermatol2006 5542545

    Not in our library10.1111/j.1365-2133.2005.07048.x

  69. 69.

    Caballero T Baeza ML Cabañas R Campos A Cimbollek S Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosisJ Investig Allergol Clin Immunol2011 5333347quiz follow 347

    Not in our library

  70. 70.

    Karim Y Griffiths H Deacock S Normal complement C4 values do not exclude hereditary angioedemaJ Clin Pathol2004 5213214

    Not in our library10.1136/jcp.2003.12021

  71. 71.

    Tarzi MD Hickey A Förster T Mohammadi M Longhurst HJ An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedemaClin Exp Immunol2007 5513516

    Not in our library10.1111/j.1365-2249.2007.03438.x

  72. 72.

    Wagenaar-Bos IG Drouet C Aygören-Pursun E Bork K Bucher C Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendationsJ Immunol Methods2008 51420

    Not in our library10.1016/j.jim.2008.06.004

  73. 73.

    Zuraw BL Diagnosis and management of hereditary angioedema: an American approachTransfus Apher Sci2003 5239245

    Not in our library10.1016/j.transci.2003.08.008

  74. 74.

    Bork K Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutationsImmunol Allergy Clin North Am2006 5709724

    Not in our library10.1016/j.iac.2006.09.003

  75. 75.

    Weiler CR van Dellen RG Genetic test indications and interpretations in patients with hereditary angioedemaMayo Clin Proc2006 5958972

    Not in our library10.4065/81.7.958

  76. 76.

    Caballero T Baeza ML Cabañas R Campos A Cimbollek S Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situationsJ Investig Allergol Clin Immunol2011 5422441quiz 442-423

    Not in our library

  77. 77.

    Temino VM Peebles RS Jr The spectrum and treatment of angioedemaAm J Med2008 5282286

    Not in our library10.1016/j.amjmed.2007.09.024

  78. 78.

    Zuberbier T Asero R Bindslev-Jensen C Walter Canonica G Church MK EAACI/GA(2)LEN/EDF/WAO guideline: management of urticariaAllergy2009 514271443

    Not in our library10.1111/j.1398-9995.2009.02178.x

  79. 79.

    Bork K Wulff K Hardt J Witzke G Staubach P Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapyJ Allergy Clin Immunol2009 5129134

    Not in our library10.1016/j.jaci.2009.03.038

  80. 80.

    Farkas H Szongoth M Kaposi PN Karádi I Fekete B Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitisActa Derm Venereol2001 5298300

    Not in our library10.1080/00015550152572985

  81. 81.

    Kaplan AP C1 inhibitor deficiency: hereditary and acquired formsJ Investig Allergol Clin Immunol2001 5211219

    Not in our library

  82. 82.

    Cugno M Castelli R Cicardi M Angioedema due to acquired C1inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferationAutoimmun Rev2008 5156159

    Not in our library10.1016/j.autrev.2008.05.003

  83. 83.

    Levi M Choi G Picavet C Hack CE Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiencyJ Allergy Clin Immunol2006 5904908

    Not in our library10.1016/j.jaci.2006.01.002

  84. 84.

    Bygum A Andersen KE Mikkelsen CS Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefitsEur J Dermatol2009 5147151

    Not in our library10.1684/ejd.2008.0603

  85. 85.

    Gras J Icatibant for hereditary angioedemaDrugs Today (Barc)2009 5855864

    Not in our library10.1358/dot.2009.45.12.1424267

  86. 86.

    Bork K Recurrent angioedema and the threat of asphyxiationDtsch Arztebl Int2010 5408414

    Not in our library10.3238/arztebl.2010.0408

  87. 87.

    Martinez-Saguer I Rusicke E Aygören-Pürsün E Heller C Klingebiel T Kreuz W Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrateAm J Obstet Gynecol2010 5131e1-e7

    Not in our library10.1016/j.ajog.2010.03.003

  88. 88.

    Groner A Nowak T Schäfer W Pathogen safety of human C1 esterase inhibitor concentrateTransfusion2012 521042112

    Not in our library10.1111/j.1537-2995.2012.03590.x

  89. 89.

    Ärzteschaft A Schwerwiegende Thrombenbildung nach Berinert® HSDeutsches Ärzteblatt2000 5A101623780551

    Not in our library

  90. 90.

    Bork K Hardt J Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrateAm J Med2009 5780783

    Not in our library10.1016/j.amjmed.2009.02.024

  91. 91.

    Bork K Hardt J Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per weekInt Arch Allergy Immunol2011 58188

    Not in our library10.1159/000319213

  92. 92.

    Varga L Farkas H Treatment of type I and II hereditary angioedema with Rhucin, a recombinant human C1 inhibitorExpert Rev Clin Immunol2008 5653661

    Not in our library10.1586/1744666x.4.6.653

  93. 93.

    Sheffer AL Campion M Levy RJ Li HH Horn PT Pullman WE Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studiesJ Allergy Clin Immunol2011 5153159.e154

    Not in our library10.1016/j.jaci.2011.03.006

  94. 94.

    Bygum A Broesby-Olsen S Rapid resolution of erythema marginatum after icatibant in acquired angioedemaActa Derm Venereol2011 5185186

    Not in our library10.2340/00015555-1055

  95. 95.

    Bork K Hardt J Staubach-Renz P Witzke G Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective studyOral Surg Oral Med Oral Pathol Oral Radiol Endod2011 55864

    Not in our library10.1016/j.tripleo.2011.02.034

  96. 96.

    Zuraw BL Hereditary angiodema: a current state-of-the-art review, IV: short-and long-term treatment of hereditary angioedema: out with the old and in with the new?Ann Allergy Asthma Immunol2008 5suppl 2S13S18

    Not in our library10.1016/s1081-1206(10)60581-9

  97. 97.

    Maurer M Magerl M Hereditary angioedema: an update on available therapeutic optionsJ Dtsch Dermatol Ges2010 5663672

    Not in our library10.1111/j.1610-0387.2010.07450.x

  98. 98.

    Van Sickels NJ Hunsaker RB Van Sickels JE Hereditary angioedema: treatment, management, and precautions in patients presenting for dental careOral Surg Oral Med Oral Pathol Oral Radiol Endod2010 5168172

    Not in our library10.1016/j.tripleo.2009.09.031

  99. 99.

    Gompels MM Lock RJ Cinryze (C1-inhibitor) for the treatment of hereditary angioedemaExpert Rev Clin Immunol2011 5569573

    Not in our library10.1586/eci.11.50

  100. 100.

    Lunn M Santos C Craig T Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safetyJ Blood Med2010 5163170

    Not in our library10.2147/jbm.s9576

  101. 101.

    Tallroth GA Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrateInt Arch Allergy Immunol2011 5356359

    Not in our library10.1159/000321830

  102. 102.

    Blackmore WP Danazol in the treatment of hereditary angio-neurotic oedemaJ Int Med Res1977 5suppl 33843

    Not in our library

  103. 103.

    Agostoni A Cicardi M Martignoni GC Bergamaschini L Marasini B Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedemaJ Allergy Clin Immunol1980 57579

    Not in our library10.1016/0091-6749(80)90181-5

  104. 104.

    Wharton JG Hereditary angioedema: response to danazolPractitioner1982 5935936

    Not in our library

  105. 105.

    Zurlo JJ Frank MM The long-term safety of danazol in women with hereditary angioedemaFertil Steril1990 56472

    Not in our library10.1016/s0015-0282(16)53638-3

  106. 106.

    Cicardi M Bergamaschini L Cugno M Hack E Agostoni G Agostoni A Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experienceJ Allergy Clin Immunol1991 5768773

    Not in our library10.1016/0091-6749(91)90120-d

  107. 107.

    Bork K Schneiders V Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedemaJ Hepatol2002 5707709

    Not in our library10.1016/s0168-8278(02)00035-1

  108. 108.

    Bork K Bygum A Hardt J Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patientsAnn Allergy Asthma Immunol2008 5153161

    Not in our library10.1016/s1081-1206(10)60424-3

  109. 109.

    Farkas H Czaller I Csuka D Vas A Valentin S The effect of long-term danazol prophylaxis on liver function in hereditary angioedemada longitudinal studyEur J Clin Pharmacol2010 5419426

    Not in our library10.1007/s00228-009-0771-z

  110. 110.

    Maurer M Magerl M Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternativesJ Dtsch Dermatol Ges2011 599107

    Not in our library10.1111/j.1610-0387.2010.07546.x

  111. 111.

    Sheffer AL Austen KF Rosen FS Tranexamic acid therapy in hereditary angioneurotic edemaN Engl J Med1972 5452454

    Not in our library10.1056/nejm197208312870907

  112. 112.

    Crosher R Intravenous tranexamic acid in the management of hereditary angio-oedemaBr J Oral Maxillofac Surg1987 5500506

    Not in our library10.1016/0266-4356(87)90143-4

  113. 113.

    Farkas H Harmat G Füst G Varga L Visy B Clinical management of hereditary angio-oedema in childrenPediatr Allergy Immunol2002 5153161

    Not in our library10.1034/j.1399-3038.2002.01014.x

  114. 114.

    Caballero T Farkas H Bouillet L Bowen T Gompel A International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiencyJ Allergy Clin Immunol2012 5308320

    Not in our library10.1016/j.jaci.2011.11.025

  115. 115.

    Boyle RJ Nikpour M Tang ML Hereditary angio-oedema in children: a management guidelinePediatr Allergy Immunol2005 5288294

    Not in our library10.1111/j.1399-3038.2005.00275.x

  116. 116.

    Farkas H Pediatric hereditary angioedema due to C1-inhibitor deficiencyAllergy Asthma Clin Immunol2010 518

    Not in our library10.1186/1710-1492-6-18

  117. 117.

    Martinez-Saguer I Rusicke E Aygören-Pürsün E von Hentig N Klingebiel T Kreuz W Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective studyTransfusion2010 5354360

    Not in our library10.1111/j.1537-2995.2009.02394.x

  118. 118.

    Caballero T Angio-oedema due to hereditary C1 inhibitor deficiency in childrenAllergol Immunopathol (Madr)2012

    Not in our library10.1016/j.aller.2012.01.002

  119. 119.

    Kjaer L Bygum A Hereditary angioedema in childhood: a challenging diagnosis you cannot afford to missPediatr Dermatol2012

    Not in our library10.1111/j.1525-1470.2011.01675.x

  120. 120.

    Davis CA Vallota EH Forristal J Serum complement levels in infancy: age related changesPediatr Res1979 510431046

    Not in our library10.1203/00006450-197909000-00019

  121. 121.

    Roach B Kim Y Jerome E Michael AF Influence of age and sex on serum complement components in childrenAm J Dis Child1981 5918920

    Not in our library10.1001/archpedi.1981.02130340030011

  122. 122.

    Nielsen EW Johansen HT Holt J Mollnes TE C1 inhibitor and diagnosis of hereditary angioedema in newbornsPediatr Res1994 5184187

    Not in our library10.1203/00006450-199402000-00012

  123. 123.

    Wahn V Aberer W Eberl W Faßhauer M Kühne T Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategiesEur J Pediatr2012 513391348

    Not in our library10.1007/s00431-012-1726-4

  124. 124.

    Yip J Cunliffe WJ Hormonally exacerbated hereditary angioedemaAustralas J Dermatol1992 53538

    Not in our library10.1111/j.1440-0960.1992.tb00050.x

  125. 125.

    Visy B Fust G Varga L Szendei G Takács E Sex hormones in hereditary angioneurotic oedemaClin Endocrinol (Oxf)2004 5508515

    Not in our library10.1111/j.1365-2265.2004.02009.x

  126. 126.

    Bouillet L Longhurst H Boccon-Gibod I Bork K Bucher C Disease expression in women with hereditary angioedemaAm J Obstet Gynecol2008 5484e1-e4

    Not in our library10.1016/j.ajog.2008.04.034

  127. 127.

    Cox M Holdcroft A Hereditary angioneurotic oedema: current management in pregnancyAnaesthesia1995 5547549

    Not in our library10.1111/j.1365-2044.1995.tb06050.x

  128. 128.

    Duvvur S Khan F Powell K Hereditary angioedema and pregnancyJ Matern Fetal Neonatal Med2007 5563565

    Not in our library10.1080/14767050701411851

  129. 129.

    Bouillet L Hereditary angioedema in womenAllergy Asthma Clin Immunol2010 517

    Not in our library10.1186/1710-1492-6-17

  130. 130.

    Czaller I Visy B Csuka D Füst G Tóth F Farkas H The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term surveyEur J Obstet Gynecol Reprod Biol2010 54449

    Not in our library10.1016/j.ejogrb.2010.05.008

  131. 131.

    Montinaro V Castellano G Management of pregnancy and vaginal delivery by C1 inhibitor concentrate in two hereditary angioedema twinsClin Immunol2010 5456457

    Not in our library10.1016/j.clim.2010.05.008

  132. 132.

    Longhurst HJ Carr S Khair K C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment optionClin Exp Immunol2007 51117

    Not in our library10.1111/j.1365-2249.2006.03256.x

  133. 133.

    Aygoren-Pursun E Martinez-Saguer I Rusicke E Klingebiel T Kreuz W On demand treatment and home therapy of hereditary angioedema in Germany--the Frankfurt experienceAllergy Asthma Clin Immunol2010 521

    Not in our library10.1186/1710-1492-6-21

  134. 134.

    Farkas H Csuka D Zotter Z Varga L Böröcz Z Home treatment of hereditary angioedema with icatibant administered by health care professionalsJ Allergy Clin Immunol2012 5851852.e2

    Not in our library10.1016/j.jaci.2011.10.039

  135. 135.

    Kreuz W Rusicke E Martinez-Saguer I Aygören-Pürsün E Heller C Klingebiel T Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedemaTransfusion2012 5100107

    Not in our library10.1111/j.1537-2995.2011.03240.x

  136. 136.

    Tourangeau LM Castaldo AJ Davis DK Koziol J Christiansen SC Zuraw BL Safety and efficacy of physician-supervised self-managed c1 inhibitor replacement therapyInt Arch Allergy Immunol2012 5417424

    Not in our library10.1159/000329635

  137. 137.

    Wilson DA Bork K Shea EP Rentz AM Blaustein MB Pullman WE Economic costs associated with acute attacks and long-term management of hereditary angioedemaAnn Allergy Asthma Immunol2010 5314320

    Not in our library10.1016/j.anai.2010.01.024

  138. 138.

    Zilberberg MD Jacobsen T Tillotson G The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007Allergy Asthma Proc2010 5511519

    Not in our library10.2500/aap.2010.31.3403

  139. 139.

    Gorman PJ Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrateCan Fam Physician2008 5365366

    Not in our library

  140. 140.

    Farkas H Fust G Fekete B Karádi I Varga L Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedemaLancet2001 516951696

    Not in our library10.1016/s0140-6736(01)06720-4

  141. 141.

    Bork K Barnstedt SE Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedemaJ Am Dent Assoc2003 510881094

    Not in our library10.14219/jada.archive.2003.0323

Cited by papers we hold 7

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.